EPIVA
Epiva is an immuno-microbiome therapeutics platform. Epiva is the next breakthrough microbiome company from Flagship VentureLabs, the innovation foundry of Flagship Ventures. As of July 12, 2016, Epiva Biosciences, Inc. was acquired by Evelo Biosciences. Epiva Biosciences, Inc. develops immunobiotic therapeutics, a class of primed bacterial interventions designed to restore normo-biosis, the microbiome signature normally found in healthy people. It focuses on treating conditions characterized by inflammation and aberrant immune responses by modulating the systemic microbiome, the host immune-bacteria interface. The company was founded in 2015 and is based in Cambridge, Massachusetts.
EPIVA
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.epiva.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon ASP.NET IIS ASP.NET 4.0 AWS Global Accelerator IIS 7
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Current Employees Featured
Official Site Inspections
http://www.epiva.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
